Harnessing Novel Imaging Approaches to Guide HIV Prevention and Cure Discoveries


Advances in imaging methodologies have greatly increased our understanding of cellular and molecular interactions in humans and animal models of diseases. Particularly in the HIV/SIV field, novel tissue and non-invasive imaging coupled with quantitative analysis has revealed key insights into mucosal viral transmission, local and systemic virus spread, host-viral dynamics, chronic inflammation/immune activation and the resultant immunopathology that drives disease progression to name a few. Imaging technologies, supplemented with high throughput immunoassays, could provide critical information for the development of vaccines needed to elicit broadly neutralizing antibodies in key tissue compartments as well as for the discovery of novel targets for immuno-therapies aiming to strengthen the effector arms of the immune system in virus eradication strategies.

In recent years we have witnessed the unprecedented development of imaging technologies at multiple levels. The goal of this imaging workshop is to bring imaging experts from inside and outside the HIV/SIV field together to discuss the strengths, limitations and applications of emerging imaging technologies that can be applied in HIV/SIV research, as well as to foster collaboration and accelerate scientific advances in vaccine development and cure research.

When: 8-9 May, 2017

Where: 5601 Fishers Lane, Rockville, MD

Scientific Organizing Committee:
Dr. Jacob Estes
Dr. Roger Le Grand
Dr. Costas Petrovas
Dr. Gabriel Victora

The meeting is co-sponsored by the National Institute of Allergy and Infectious Diseases and the Global HIV Vaccine Enterprise.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account